thyroid medication and glp 1 glp-1 cancer risk No Increased for in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin Semaglutide: What we know about – Semaglutide and Thyroid Health: What

10.1016/j.bbrc.2010.12.131 21 HamalS.CherukuriL.ShaikhK.KinningerA.DoshiJ.BirudarajuD.et al (2020)

Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis

Appropriate sample size was determined post-hoc so that the sample size could be increased, if necessary, so that statistical significance would be achieved if it existed

In fact, after ~68 weeks on the drug, roughly 40% of the weight is regained within 3 months of stopping the medication

Res 72 , 603612 (2003)

This notion implies that, although favorable results have been reported for clinical studies, the paucity of existing data warrants the need for further ventures in order to further elucidate the favorable effects of GLP-1 in heart failure patients [82]